ValiRx Plc Share Price London S.E.
Equities
GB00B23N9136
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
07-03 | EXECUTIVE CHANGES: Jadestone Energy's CFO Bert-Jaap Dijkstra to leave | AN |
06-19 | ValiRx Chairman Resigns | MT |
Sales 2022 | - | Sales 2023 | 0.01 0.74 | Capitalization | 6.04M 466M |
---|---|---|---|---|---|
Net income 2022 | -2M -154M | Net income 2023 | -2M -154M | EV / Sales 2022 | - |
Net cash position 2022 | 1.1M 84.82M | Net cash position 2023 | 153K 11.77M | EV / Sales 2023 | 612,941,875 x |
P/E ratio 2022 |
-4.57
x | P/E ratio 2023 |
-2.94
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.16% |
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Gerald Desler
DFI | Director of Finance/CFO | 79 | 31/08/06 |
Chief Tech/Sci/R&D Officer | - | 07/09/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Desler
DFI | Director of Finance/CFO | 79 | 31/08/06 |
Director/Board Member | 57 | 04-21 | |
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |